[8-K] AXCELIS TECHNOLOGIES INC Reports Material Event

Rhea-AI Filing Summary

Axcelis Technologies (ACLS) furnished an update on its recent performance. The company filed a Form 8‑K to report that it issued a press release covering financial results for the quarter ended September 30, 2025.

The press release is included as Exhibit 99.1 and is incorporated by reference. This filing was made under Item 2.02 (Results of Operations and Financial Condition), a standard mechanism companies use to share quarterly results.

false 0001113232 0001113232 2025-11-04 2025-11-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 4, 2025

Axcelis Technologies, Inc.

(Exact name of registrant as specified in its charter)

Delaware		000-30941		34-1818596
(State or other jurisdiction		(Commission		(IRS Employer
of incorporation)		File Number)		Identification No.)

108 Cherry Hill Drive, Beverly, Massachusetts		01915
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (978) 787-4000

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	ACLS	NASDAQ Global Select Market

Item 2.02 Results of Operations and Financial Condition

On November 4, 2025, Axcelis Technologies, Inc. (the “Company”) issued a press release regarding its financial results for its quarter ended September 30, 2025. The Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

Exhibit No.		Description
99.1		Press Release dated November 4, 2025. Filed herewith
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: November 4, 2025	Axcelis Technologies, Inc.
	By:	/s/ James Coogan
		James Coogan
		Executive Vice President and Chief Financial Officer

3 

FAQ

What did Axcelis Technologies (ACLS) file?

Axcelis filed a Form 8‑K reporting it issued a press release with financial results for the quarter ended September 30, 2025.

Which period does the ACLS update cover?

It covers the quarter ended September 30, 2025.

What exhibit contains the earnings press release?

The press release is attached as Exhibit 99.1 and incorporated by reference.

Under which item was this 8‑K furnished?

Item 2.02 — Results of Operations and Financial Condition.

What is Axcelis’s stock listing information?

Common Stock trading symbol ACLS on the NASDAQ Global Select Market.

Who signed the filing for ACLS?

It was signed by James Coogan, Executive Vice President and Chief Financial Officer.

When was the report dated?

The report is dated November 4, 2025.